@elilillyco - IGDataHub

Eli Lilly and Company

Threads

@elilillyco

100.4K

Followers

Following

951

Posts

N/A

Reels

Highlights

6/6

Photos/Videos in last 12

Bio

We're a medicine company turning science into healing to make life better for people around the world. Social Guidelines: https://e.lilly/guidelines

Links

link.lilly.com/us

Avg likes

Avg comments

Engagement

2.0/wk

Posting

Likes and comments are still being collected for this account. Check back shortly.

#wearelilly #fallclinical26 #breastcancerawarenessmonth #easd2026

Recent posts

Psoriatic arthritis can affect how people feel and function in daily life. When they also live with obesity, managing their health and achieving disease control can be more complex. New research is looking at these conditions together, helping to build a broader understanding of what may be possible when they aren’t treated in isolation. Visit our link in bio to learn more. 11 Nov 2026

Obstructive sleep apnea (OSA) repeatedly pauses breathing during sleep and can affect heart health. In a new study, our oral GLP-1 pill reduced these breathing interruptions by up to 43.8% and up to 27.5% in adults with moderate-to-severe OSA and obesity not using and using PAP therapy, respectively. Learn more at the link in bio. 09 Nov 2026

80% of heart disease and stroke is preventable, according to the American Heart Association. Yet cardiovascular disease is still the world’s leading cause of death. Closing that gap starts with finding risk earlier, so a heart attack or stroke isn’t the first warning sign. 07 Nov 2026

Some people hear “breast cancer” and think of a single diagnosis, treatment path or experience. But there are several types of breast cancer, and knowing the differences can help inform what comes next. Developed in partnership with @katiecouricmedia for #BreastCancerAwarenessMonth, we’re sharing why the type of breast cancer matters, what it can mean for treatment and what to ask a care team. Learn more at the link in our bio. #WeAreLilly 28 Oct 2026

Type 2 diabetes can make weight loss harder. In a study directly comparing two medications, our investigational triple-hormone medicine delivered greater reductions in A1C and more than double the weight loss compared with an injectable GLP-1 at 80 weeks in adults with type 2 diabetes. Learn more at the link in our bio. 28 Oct 2026

Today we were in Goochland County, VA kicking off construction of the future home of next-generation cancer medicines. Two groundbreakings in two months. One commitment: investing in U.S. manufacturing. Read more about how this new site will further the innovation of cancer treatment, create new jobs in the area and use new technologies to enable us to reach people faster in ways that matter. Link in bio. #WeAreLilly 22 Oct 2026

At #FallClinical26, we’re moving atopic dermatitis (AD) care forward — with research that keeps the needs of people living with AD at the center. #WeAreLilly 10 Oct 2026

People living with both psoriasis and obesity carry a compounded burden that extends beyond what is visible. A new exploratory analysis presented at #FallClinical26 offers insights into the connected immune and metabolic biology between these conditions, and biomarker changes observed with a comprehensive approach to treatment. See link in bio for the latest. 09 Oct 2026

How do you change the course of cardiometabolic health? At #EASD2026 in Milan, we connected with the global community to talk about what's possible as science advances and new approaches to care emerge. #WeAreLilly 08 Oct 2026

Watch Katie Giblin, a leader on our Medical Development team, break down new results from a recent clinical trial that tested how a single medicine developed to work on three different pathways performed in adults living with obesity and type 2 diabetes. 02 Oct 2026

Ever wonder how your body knows when you're full? Meet amylin — a hormone your body releases after eating to signal satiety in the brain. Ruth Gimeno, group vice president of diabetes and metabolic research, breaks down how amylin works in the body, and how an amylin receptor agonist can mimic that natural signal to the brain. #WeAreLilly 02 Oct 2026

We recently shared results from our largest and longest study yet of our oral GLP-1 medicine in people with type 2 diabetes. To break down what the findings mean, Rachel Batterham, our senior vice president of medical innovation and external engagement, and Tori Brown, our senior vice president of global customer experience and product strategy, discuss the results and how they build a strong foundation for future studies. 01 Oct 2026

Follower tracking

We have started recording @elilillyco, but only 1 observation so far — not enough to show a trend yet. Track it daily →

Download @elilillyco's data

Everything below is derived from this account, priced on the counts shown. Delivered as CSV by emailed link.

Data

Records

What you get

Price

Every post & reel

951 posts & reels

Caption, likes, comments, views, duration, mentions, co-authors and sponsored status for every post and reel.

See a sample

shortcode	caption	likes	comments
DfmxrFXF6Nf	Psoriatic arthritis can affect how people feel a…
DfhlXCVF2tj	Obstructive sleep apnea (OSA) repeatedly pauses …
DfaFV10iCfm	80% of heart disease and stroke is preventable, …

Real rows from this account. The file continues in the same shape.

$9.99

minimum

Everyone who follows them

up to 50,000 followers of 100,368 total

Handle, full name, ID, and verified/private flags for each follower.

See the columns

username	full_name	user_id	is_verified	is_private	profile_pic_url

These are the columns. We can't show live rows: Instagram serves no follower or following list to a logged-out client, so we hold none until you order.

$250.00

Everyone they follow

up to 61 accounts

Every account this one follows, same fields.

See the columns

username	full_name	user_id	is_verified	is_private	profile_pic_url

These are the columns. We can't show live rows: Instagram serves no follower or following list to a logged-out client, so we hold none until you order.

$9.99

minimum

Every post & reel

951 posts & reels

$9.99

minimum

Caption, likes, comments, views, duration, mentions, co-authors and sponsored status for every post and reel.

See a sample

shortcode	caption	likes	comments
DfmxrFXF6Nf	Psoriatic arthritis can affect how people feel a…
DfhlXCVF2tj	Obstructive sleep apnea (OSA) repeatedly pauses …
DfaFV10iCfm	80% of heart disease and stroke is preventable, …

Real rows from this account. The file continues in the same shape.

Everyone who follows them

up to 50,000 followers of 100,368 total

$250.00

Handle, full name, ID, and verified/private flags for each follower.

See the columns

username	full_name	user_id	is_verified	is_private	profile_pic_url

These are the columns. We can't show live rows: Instagram serves no follower or following list to a logged-out client, so we hold none until you order.

Everyone they follow

up to 61 accounts

$9.99

minimum

Every account this one follows, same fields.

See the columns

username	full_name	user_id	is_verified	is_private	profile_pic_url

These are the columns. We can't show live rows: Instagram serves no follower or following list to a logged-out client, so we hold none until you order.

You only pay for rows we deliver. Counts are the maximum available today; if an export comes back smaller, the difference is refunded automatically. Counts as last collected 1 day, 13 hours ago.

Tracking

A monthly plan, not a download: we keep reading @elilillyco and email you what changed.

Track @elilillyco every day · up to 5 accounts

We read @elilillyco daily from today and email you the week's follower, following and post changes, with every reading so far as a CSV. Add up to 4 more accounts on the same plan. Cancel any time.

See the columns